Evidence map›Paper›PMID 42781102›Full record

ArticleBMJ public health2026

Mortality and recurrent events after first hospitalisation for heart failure and pulmonary heart disease: a community-based prospective study of 0.5 million Chinese adults.

Valirie Ndip Agbor, Yiping Chen, Neil Wright, Christiana Kartsonaki, Jun Lv, Pei Pei, Dianjianyi Sun, Canqing Yu, Liming Li, Zhengming Chen and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Valirie Ndip AgborNuffield Department of Population Health, University of Oxford, Oxford, England, UK.
Yiping ChenNuffield Department of Population Health, University of Oxford, Oxford, England, UK.
Neil WrightNuffield Department of Population Health, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0002-3946-1870
Christiana KartsonakiNuffield Department of Population Health, University of Oxford, Oxford, England, UK.
Jun LvPeking University School of Public Health Department of Epidemiology and Biostatistics, Beijing, China.
Pei PeiPeking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
Dianjianyi SunPeking University School of Public Health Department of Epidemiology and Biostatistics, Beijing, China.
Canqing YuPeking University School of Public Health Department of Epidemiology and Biostatistics, Beijing, China.
Liming LiPeking University School of Public Health Department of Epidemiology and Biostatistics, Beijing, China.
Zhengming ChenNuffield Department of Population Health, University of Oxford, Oxford, England, UK.
Wei JiangNCD Prevention and Control Department, Pengzou CDC, Sichuan, China.
Dan Valle SchmidtNuffield Department of Population Health, University of Oxford, Oxford, England, UK.
Maxim BarnardNuffield Department of Population Health, University of Oxford, Oxford, England, UK.
Robert ClarkeNuffield Department of Population Health, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0002-9802-8241
Derrick BennettNuffield Department of Population Health, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0002-9170-8447

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: Little is known about inequalities in prognosis of heart failure (HF) and pulmonary heart disease (PHD) in low-income and middle-income countries. The aims of this study were to compare hospitalisation and mortality rates between HF and PHD cases in Chinese adults. Methods: In a prospective study of 512 724 adults from 10 areas in China Kadoorie Biobank enrolled in 2004-2008, data on first hospitalisations were obtained by linkage to hospitalisation and death registers. Outcomes included 28-day case-fatality ratio (CFR), 5-year cumulative mortality risks (CMR) and 5-year recurrent hospitalisations following first hospital admissions with HF or PHD. Results: Among first incident hospitalisations with HF (n=7461) and PHD (n=5925), the hospitalisation rates (95% CI) for HF were 125 (122 to 128) and PHD were 99 (96 to 101) per 10 Conclusions: Half of all first HF and three-quarters of first PHD cases died within 5 years, highlighting the urgent need to improve treatment for HF and PHD cases in China.

Indexed as

Cardiovascular DiseasesEpidemiological MonitoringEpidemiologyPublic Health Practice

Identifiers

PMID42781102
PMCPMC13599994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.